Valeo Financial Advisors, LLC Vbi Vaccines Inc Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$2.61 - $4.17 $2,610 - $4,170	-1,000 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$2.91 - $4.32 $2,910 - $4,320	1,000 New	1,000 $3,000
Q4 2020 Feb 11, 2021	SELL	$2.15 - $3.5 $1,075 - $1,750	-500 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$2.77 - $6.17 $1,385 - $3,085	500 New	500 $1,000
Q2 2020 Jul 20, 2020	BUY	$0.87 - $3.13 $0 - $0	0 New	0 $0

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.